chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myocardial ischaemia, Procalcitonin, SARS-CoV-2 test positive, Septic shock, Transaminases increased
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 8/31/21 and 9/21/21. Covid+ 1/23/22. Admitted to ED on 1/26/22 for AMS. Minimally responsive and hypotensive on admission, dx'd w/septic shock 2/2 Covid19 c/b severely hypernatremic & dehydrated w/acute kidney failure, NSTEMI (likely demand), transaminitis and metabolic encephalopathy. Initial labs showed:  Na+ 186, glu 161, BUN 184, Cr. 7.04, Alk Phos 190, trop 0.21, procal 0.57, COVID positive. Transitioned to comfort care. Treated with vancomycin and zosyn. Pt expired on 2/9/2022.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 8/31/21 and 9/21/21. Covid+ 1/23/22. Admitted to ED on 1/26/22 for AMS. Minimally responsive and hypotensive on admission, dx'd w/septic shock 2/2 Covid19 c/b severely hypernatremic & dehydrated w/acute kidney failure, NSTEMI (likely demand), transaminitis and metabolic encephalopathy. Initial labs showed:  Na+ 186, glu 161, BUN 184, Cr. 7.04, Alk Phos 190, trop 0.21, procal 0.57, COVID positive. Transitioned to comfort care. Treated with vancomycin and zosyn. Pt expired on 2/9/2022.
Age: 99.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Vaccinated pt admitted to inpatient facility with covid infection
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: Acute kidney injury, Acute respiratory failure, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 2/03/21, 3/04/21. Covid + 2/03/22. Presented to ED 1/8/22 after fall at home admitted for acute hypoxic resp failure and acute encephalopathy 2/2 Covid PNA, tx'd  w/IV Abx and steroids, transferred to rehab facility 1/15/22.  At rehab facility had increasing SOB and cough. Readmitted 2/26/22 w/PE and acute renal failure. 1/29/22: CXR showing worsening right sided infiltrates and pulmonary congestion and aspiration PNA. Continued to deteriorate, transitioned to comfort care. Tx'd with cefepine and zosyn during current admission. Expired on 2/07/2022.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: Cough, Death, Dyspnoea, Encephalopathy, Fall
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 2/03/21, 3/04/21. Covid + 2/03/22. Presented to ED 1/8/22 after fall at home admitted for acute hypoxic resp failure and acute encephalopathy 2/2 Covid PNA, tx'd  w/IV Abx and steroids, transferred to rehab facility 1/15/22.  At rehab facility had increasing SOB and cough. Readmitted 2/26/22 w/PE and acute renal failure. 1/29/22: CXR showing worsening right sided infiltrates and pulmonary congestion and aspiration PNA. Continued to deteriorate, transitioned to comfort care. Tx'd with cefepine and zosyn during current admission. Expired on 2/07/2022.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: General physical health deterioration, Inappropriate schedule of product administration, Lung infiltration, Pneumonia aspiration, Pulmonary congestion
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 2/03/21, 3/04/21. Covid + 2/03/22. Presented to ED 1/8/22 after fall at home admitted for acute hypoxic resp failure and acute encephalopathy 2/2 Covid PNA, tx'd  w/IV Abx and steroids, transferred to rehab facility 1/15/22.  At rehab facility had increasing SOB and cough. Readmitted 2/26/22 w/PE and acute renal failure. 1/29/22: CXR showing worsening right sided infiltrates and pulmonary congestion and aspiration PNA. Continued to deteriorate, transitioned to comfort care. Tx'd with cefepine and zosyn during current admission. Expired on 2/07/2022.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 2/03/21, 3/04/21. Covid + 2/03/22. Presented to ED 1/8/22 after fall at home admitted for acute hypoxic resp failure and acute encephalopathy 2/2 Covid PNA, tx'd  w/IV Abx and steroids, transferred to rehab facility 1/15/22.  At rehab facility had increasing SOB and cough. Readmitted 2/26/22 w/PE and acute renal failure. 1/29/22: CXR showing worsening right sided infiltrates and pulmonary congestion and aspiration PNA. Continued to deteriorate, transitioned to comfort care. Tx'd with cefepine and zosyn during current admission. Expired on 2/07/2022.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Respiratory tract congestion, SARS-CoV-2 test positive, Sinusitis
Clinical narrative: Congestion, sinus infection, and cough. Treated initially with Amoxicillin on 1/5/22.  Not improved on 1/14/22 so visited with Dr. via email and was asked to take a Covid-19 test. Also prescribed Benzonatate.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Intermittent claudication, Pain, Peripheral endarterectomy, Revascularisation procedure, Stent placement
Clinical narrative: Patient presented to the Clinic with the abrupt onset of short-distance right lower extremity claudication and early rest pain; underwent a right transinguinal hybrid revascularization, which consisted of right common femoral, superficial femoral, and profunda femoral artery endarterectomy with vein patch angioplasty and right external iliac to right femoral (patch) self-expanding stent graft placement. Discharged home. This admission was within 6 weeks of receiving the COVID vaccine.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Venous angioplasty
Clinical narrative: Patient presented to the Clinic with the abrupt onset of short-distance right lower extremity claudication and early rest pain; underwent a right transinguinal hybrid revascularization, which consisted of right common femoral, superficial femoral, and profunda femoral artery endarterectomy with vein patch angioplasty and right external iliac to right femoral (patch) self-expanding stent graft placement. Discharged home. This admission was within 6 weeks of receiving the COVID vaccine.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Event occurred after 2nd vaccine. First vaccine was on 3/9/21 and the second one on 4/6/21.Pt tested positive for COVID-19 on  11/16/21.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood creatinine increased, Blood pH decreased, Blood sodium decreased, COVID-19, Death
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 1/15/21, 3/04/21, and 3/25/21. Covid + 1/18/22. Presented to ED 1/27 w/symptoms x9 days related to COVID-19 infection. In ED, vitals showed T 99.4F, BP 104/70 mmHg, satting 99% on RA. Metabolic acidosis (venous pH 7.29), elevated Cr of 1.96, Na 133. Morning of 01/31, acutely desatted to mid 80s and developed mild tachypnea, later fevered to 102.2F placed on CPAP. Continued to deteriorate, transitioned to DNAR. Tx'd with cefepine remdesivir, dexamethasone and vancomycin. Pt expired on 2/11/2022.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Extra dose administered, General physical health deterioration, Inappropriate schedule of product administration, Malaise, Metabolic acidosis
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 1/15/21, 3/04/21, and 3/25/21. Covid + 1/18/22. Presented to ED 1/27 w/symptoms x9 days related to COVID-19 infection. In ED, vitals showed T 99.4F, BP 104/70 mmHg, satting 99% on RA. Metabolic acidosis (venous pH 7.29), elevated Cr of 1.96, Na 133. Morning of 01/31, acutely desatted to mid 80s and developed mild tachypnea, later fevered to 102.2F placed on CPAP. Continued to deteriorate, transitioned to DNAR. Tx'd with cefepine remdesivir, dexamethasone and vancomycin. Pt expired on 2/11/2022.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oxygen saturation decreased, Positive airway pressure therapy, Pyrexia, SARS-CoV-2 test positive, Tachypnoea
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 1/15/21, 3/04/21, and 3/25/21. Covid + 1/18/22. Presented to ED 1/27 w/symptoms x9 days related to COVID-19 infection. In ED, vitals showed T 99.4F, BP 104/70 mmHg, satting 99% on RA. Metabolic acidosis (venous pH 7.29), elevated Cr of 1.96, Na 133. Morning of 01/31, acutely desatted to mid 80s and developed mild tachypnea, later fevered to 102.2F placed on CPAP. Continued to deteriorate, transitioned to DNAR. Tx'd with cefepine remdesivir, dexamethasone and vancomycin. Pt expired on 2/11/2022.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Bone disorder, Limb operation, Magnetic resonance imaging, Osteomyelitis
Clinical narrative: I develop a bone injection in my finger tips.  I can not get rid of it.  These have been going on in October and is still continuing today.  I been to my doctor about this.  They did blood work and MRI on me. I had two surgeries and it has not helps resolve this.  I was diagnosed with osteomyelitis.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, COVID-19, COVID-19 pneumonia, Death, Endotracheal intubation
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Moderna Vaccines on 3/1/2021 and 3/29/2021. Presented to ED for COVID and failure to thrive. Per family COVID symptom onset 1/12/2022. Admitted to floor but transferred to ICU on maximized HFNC with oxygen saturation on the low 80's. Intubated on 2/6/2022. Developed worsening shock likely septic. Developed GI bleed due to mesenteric ischemia. Hemodynamics continued to decompensate. Tx'd w/dexamethasone, antibiotics, and pressors. Code status changed to DNR, expired 2/14/22.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Failure to thrive, Gastrointestinal haemorrhage, Haemodynamic instability, Intensive care, Intestinal ischaemia
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Moderna Vaccines on 3/1/2021 and 3/29/2021. Presented to ED for COVID and failure to thrive. Per family COVID symptom onset 1/12/2022. Admitted to floor but transferred to ICU on maximized HFNC with oxygen saturation on the low 80's. Intubated on 2/6/2022. Developed worsening shock likely septic. Developed GI bleed due to mesenteric ischemia. Hemodynamics continued to decompensate. Tx'd w/dexamethasone, antibiotics, and pressors. Code status changed to DNR, expired 2/14/22.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lung opacity, Malaise, Pulmonary embolism, SARS-CoV-2 test positive, Septic shock
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Moderna Vaccines on 3/1/2021 and 3/29/2021. Presented to ED for COVID and failure to thrive. Per family COVID symptom onset 1/12/2022. Admitted to floor but transferred to ICU on maximized HFNC with oxygen saturation on the low 80's. Intubated on 2/6/2022. Developed worsening shock likely septic. Developed GI bleed due to mesenteric ischemia. Hemodynamics continued to decompensate. Tx'd w/dexamethasone, antibiotics, and pressors. Code status changed to DNR, expired 2/14/22.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Formication, Paraesthesia
Clinical narrative: Patient reported "For 8 days and nights I had the tingling/crawling feeling in my arms and legs, sometimes my body felt that. After that went away I have not had any other symptoms."
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted to inpatient facility with covid infection
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Bradycardia, COVID-19, Cardiac arrest, Chest pain
Clinical narrative: Pfizer COVID Vaccine: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/4/2021 and 3/25/2021. Presented to ED 2/17/2022 c/o intermittent chest pain x1 week progressing to severe. EKG showed inferior STEMI sent to cathlab unable to pass wire, CP resolved. Elevated white count and procalcitonin, started on iv abx. 2/18/22 Covid+. Later had a cardiac arrest ACLS x/multiple rounds w/ROSC, intubated. Subsequent CT scan showed probable perforation near the GE junction w/hematoma near spleen. Renal failure and was started on CRRT, circuit kept clotting due to her severe illness and COVID, unable to dialyze. Continued to decompensate and then had severe bradycardia tx'd with transcutaneous pacing and eventually the family made her DNR. Expired on 2/19/2022.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram abnormal, Death, Dialysis related complication, Electrocardiogram abnormal, Endotracheal intubation
Clinical narrative: Pfizer COVID Vaccine: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/4/2021 and 3/25/2021. Presented to ED 2/17/2022 c/o intermittent chest pain x1 week progressing to severe. EKG showed inferior STEMI sent to cathlab unable to pass wire, CP resolved. Elevated white count and procalcitonin, started on iv abx. 2/18/22 Covid+. Later had a cardiac arrest ACLS x/multiple rounds w/ROSC, intubated. Subsequent CT scan showed probable perforation near the GE junction w/hematoma near spleen. Renal failure and was started on CRRT, circuit kept clotting due to her severe illness and COVID, unable to dialyze. Continued to decompensate and then had severe bradycardia tx'd with transcutaneous pacing and eventually the family made her DNR. Expired on 2/19/2022.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Haemofiltration, Illness, Life support, Perforation, Procalcitonin
Clinical narrative: Pfizer COVID Vaccine: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/4/2021 and 3/25/2021. Presented to ED 2/17/2022 c/o intermittent chest pain x1 week progressing to severe. EKG showed inferior STEMI sent to cathlab unable to pass wire, CP resolved. Elevated white count and procalcitonin, started on iv abx. 2/18/22 Covid+. Later had a cardiac arrest ACLS x/multiple rounds w/ROSC, intubated. Subsequent CT scan showed probable perforation near the GE junction w/hematoma near spleen. Renal failure and was started on CRRT, circuit kept clotting due to her severe illness and COVID, unable to dialyze. Continued to decompensate and then had severe bradycardia tx'd with transcutaneous pacing and eventually the family made her DNR. Expired on 2/19/2022.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Renal failure, SARS-CoV-2 test positive, Splenic haematoma, Thrombosis in device, Transcutaneous pacing
Clinical narrative: Pfizer COVID Vaccine: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/4/2021 and 3/25/2021. Presented to ED 2/17/2022 c/o intermittent chest pain x1 week progressing to severe. EKG showed inferior STEMI sent to cathlab unable to pass wire, CP resolved. Elevated white count and procalcitonin, started on iv abx. 2/18/22 Covid+. Later had a cardiac arrest ACLS x/multiple rounds w/ROSC, intubated. Subsequent CT scan showed probable perforation near the GE junction w/hematoma near spleen. Renal failure and was started on CRRT, circuit kept clotting due to her severe illness and COVID, unable to dialyze. Continued to decompensate and then had severe bradycardia tx'd with transcutaneous pacing and eventually the family made her DNR. Expired on 2/19/2022.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Pfizer COVID Vaccine: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/4/2021 and 3/25/2021. Presented to ED 2/17/2022 c/o intermittent chest pain x1 week progressing to severe. EKG showed inferior STEMI sent to cathlab unable to pass wire, CP resolved. Elevated white count and procalcitonin, started on iv abx. 2/18/22 Covid+. Later had a cardiac arrest ACLS x/multiple rounds w/ROSC, intubated. Subsequent CT scan showed probable perforation near the GE junction w/hematoma near spleen. Renal failure and was started on CRRT, circuit kept clotting due to her severe illness and COVID, unable to dialyze. Continued to decompensate and then had severe bradycardia tx'd with transcutaneous pacing and eventually the family made her DNR. Expired on 2/19/2022.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: THE PATIENT WAS 15 YEARS OLD AT THE TIME AND SHOULD HAVE RECEIVED PFIZER AND NOT MODERNA.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Anticoagulant therapy, Blood culture positive, COVID-19
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine: COVID-19 case resulting in Hospitalization / Death. Received Pfizer-BioNTech Vaccines on 8/2/2021 and 8/24/2021. Presented to outside facility 1/24/22 with SOB and COVID positive, c/b PE w/cor pulmonale and right popliteal non-occlusive DVT. Tx'd w/tPA and IVC filter. Initially improved until 2/1/2022 decompensated w/cardiogenic shock and respiratory failure requiring intubation. Transferred to Hospital. Impella placed 2/3/2022 to 2/8/2022. Received antibiotics for MRSA bacteremia and CRRT for acute kidney injury. Tx'd methylprednisolone, anticoagulation, and pressor/ionotrope. Transitioned to palliative care 2/15/2022, expired same day.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiogenic shock, Cor pulmonale, Death, Deep vein thrombosis, Dyspnoea
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine: COVID-19 case resulting in Hospitalization / Death. Received Pfizer-BioNTech Vaccines on 8/2/2021 and 8/24/2021. Presented to outside facility 1/24/22 with SOB and COVID positive, c/b PE w/cor pulmonale and right popliteal non-occlusive DVT. Tx'd w/tPA and IVC filter. Initially improved until 2/1/2022 decompensated w/cardiogenic shock and respiratory failure requiring intubation. Transferred to Hospital. Impella placed 2/3/2022 to 2/8/2022. Received antibiotics for MRSA bacteremia and CRRT for acute kidney injury. Tx'd methylprednisolone, anticoagulation, and pressor/ionotrope. Transitioned to palliative care 2/15/2022, expired same day.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, Haemofiltration, Inappropriate schedule of product administration, Pulmonary embolism, Respiratory failure
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine: COVID-19 case resulting in Hospitalization / Death. Received Pfizer-BioNTech Vaccines on 8/2/2021 and 8/24/2021. Presented to outside facility 1/24/22 with SOB and COVID positive, c/b PE w/cor pulmonale and right popliteal non-occlusive DVT. Tx'd w/tPA and IVC filter. Initially improved until 2/1/2022 decompensated w/cardiogenic shock and respiratory failure requiring intubation. Transferred to Hospital. Impella placed 2/3/2022 to 2/8/2022. Received antibiotics for MRSA bacteremia and CRRT for acute kidney injury. Tx'd methylprednisolone, anticoagulation, and pressor/ionotrope. Transitioned to palliative care 2/15/2022, expired same day.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Staphylococcal bacteraemia, Staphylococcus test positive, Vena cava filter insertion
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine: COVID-19 case resulting in Hospitalization / Death. Received Pfizer-BioNTech Vaccines on 8/2/2021 and 8/24/2021. Presented to outside facility 1/24/22 with SOB and COVID positive, c/b PE w/cor pulmonale and right popliteal non-occlusive DVT. Tx'd w/tPA and IVC filter. Initially improved until 2/1/2022 decompensated w/cardiogenic shock and respiratory failure requiring intubation. Transferred to Hospital. Impella placed 2/3/2022 to 2/8/2022. Received antibiotics for MRSA bacteremia and CRRT for acute kidney injury. Tx'd methylprednisolone, anticoagulation, and pressor/ionotrope. Transitioned to palliative care 2/15/2022, expired same day.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: NO ADVERSE INCIDENT. ONLY HALF OF PRESCRIBED DOSE WAS GIVEN (0.15MG INSTEAD OF 0.3MG ).  PREDILUTED VACCINE WAS DILUTED WITH NORMAL SALINE.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Lactic acidosis, Pneumonia, Sepsis
Clinical narrative: COPD exacerbation with pneumonia was treated with ceftiaxone and doxycycline as well as nebs and steroid.  UTI was also treated and pt was noted with sepsis and lactic acidosis. Discharged to home. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: COPD exacerbation with pneumonia was treated with ceftiaxone and doxycycline as well as nebs and steroid.  UTI was also treated and pt was noted with sepsis and lactic acidosis. Discharged to home. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Biopsy lung normal, Bronchoscopy, COVID-19, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 2/09/21, 3/09/21, and 8/31/21.  Covid + 1/09/22. Previously admitted for  covid19 (10/2021 tx remdesivir and dexamethasone), leukopenia,  presented 12/26-12/30/21 with fevers, cough and mass like left upper lobe consolidation found. New right lower lobe nodules 1.6 cm, multiple ground glass opacities present. Underwent bronchoscopy on 12/30/21, fungitel negative. Tx'd w/cefepime and vancomcyin.  D/C'd 01/03/2022.  Presented with fevers, tx'd x10 days of abx, completed 1/16/22. Presented to ED 1/26/22 with fatigue, fever, and malaise, admitted for PNA, UTI, thrombocytopenia, mild neutropenia, dehydration and malnutrition.  CT chest showed increased left upper lobe mass, new left sided effusions, increased nodules, all worrisome for metastatic disease.  CT guided bx of lung mass via IR 1/27/22, negative for malignancy. Continued to deteriorate, transitioned to comfort care. Tx'd w/Vancomycin, Cefepime, flagyl, Zosyn, and  isavuconazonium. Expired on 2/9/2022
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Death, Dehydration, Fatigue, Fungal test negative
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 2/09/21, 3/09/21, and 8/31/21.  Covid + 1/09/22. Previously admitted for  covid19 (10/2021 tx remdesivir and dexamethasone), leukopenia,  presented 12/26-12/30/21 with fevers, cough and mass like left upper lobe consolidation found. New right lower lobe nodules 1.6 cm, multiple ground glass opacities present. Underwent bronchoscopy on 12/30/21, fungitel negative. Tx'd w/cefepime and vancomcyin.  D/C'd 01/03/2022.  Presented with fevers, tx'd x10 days of abx, completed 1/16/22. Presented to ED 1/26/22 with fatigue, fever, and malaise, admitted for PNA, UTI, thrombocytopenia, mild neutropenia, dehydration and malnutrition.  CT chest showed increased left upper lobe mass, new left sided effusions, increased nodules, all worrisome for metastatic disease.  CT guided bx of lung mass via IR 1/27/22, negative for malignancy. Continued to deteriorate, transitioned to comfort care. Tx'd w/Vancomycin, Cefepime, flagyl, Zosyn, and  isavuconazonium. Expired on 2/9/2022
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: General physical health deterioration, Inappropriate schedule of product administration, Leukopenia, Lung consolidation, Lung opacity
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 2/09/21, 3/09/21, and 8/31/21.  Covid + 1/09/22. Previously admitted for  covid19 (10/2021 tx remdesivir and dexamethasone), leukopenia,  presented 12/26-12/30/21 with fevers, cough and mass like left upper lobe consolidation found. New right lower lobe nodules 1.6 cm, multiple ground glass opacities present. Underwent bronchoscopy on 12/30/21, fungitel negative. Tx'd w/cefepime and vancomcyin.  D/C'd 01/03/2022.  Presented with fevers, tx'd x10 days of abx, completed 1/16/22. Presented to ED 1/26/22 with fatigue, fever, and malaise, admitted for PNA, UTI, thrombocytopenia, mild neutropenia, dehydration and malnutrition.  CT chest showed increased left upper lobe mass, new left sided effusions, increased nodules, all worrisome for metastatic disease.  CT guided bx of lung mass via IR 1/27/22, negative for malignancy. Continued to deteriorate, transitioned to comfort care. Tx'd w/Vancomycin, Cefepime, flagyl, Zosyn, and  isavuconazonium. Expired on 2/9/2022
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, Malnutrition, Neutropenia, Pleural effusion, Pneumonia
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 2/09/21, 3/09/21, and 8/31/21.  Covid + 1/09/22. Previously admitted for  covid19 (10/2021 tx remdesivir and dexamethasone), leukopenia,  presented 12/26-12/30/21 with fevers, cough and mass like left upper lobe consolidation found. New right lower lobe nodules 1.6 cm, multiple ground glass opacities present. Underwent bronchoscopy on 12/30/21, fungitel negative. Tx'd w/cefepime and vancomcyin.  D/C'd 01/03/2022.  Presented with fevers, tx'd x10 days of abx, completed 1/16/22. Presented to ED 1/26/22 with fatigue, fever, and malaise, admitted for PNA, UTI, thrombocytopenia, mild neutropenia, dehydration and malnutrition.  CT chest showed increased left upper lobe mass, new left sided effusions, increased nodules, all worrisome for metastatic disease.  CT guided bx of lung mass via IR 1/27/22, negative for malignancy. Continued to deteriorate, transitioned to comfort care. Tx'd w/Vancomycin, Cefepime, flagyl, Zosyn, and  isavuconazonium. Expired on 2/9/2022
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary mass, Pyrexia, SARS-CoV-2 test positive, Thrombocytopenia, Urinary tract infection
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 2/09/21, 3/09/21, and 8/31/21.  Covid + 1/09/22. Previously admitted for  covid19 (10/2021 tx remdesivir and dexamethasone), leukopenia,  presented 12/26-12/30/21 with fevers, cough and mass like left upper lobe consolidation found. New right lower lobe nodules 1.6 cm, multiple ground glass opacities present. Underwent bronchoscopy on 12/30/21, fungitel negative. Tx'd w/cefepime and vancomcyin.  D/C'd 01/03/2022.  Presented with fevers, tx'd x10 days of abx, completed 1/16/22. Presented to ED 1/26/22 with fatigue, fever, and malaise, admitted for PNA, UTI, thrombocytopenia, mild neutropenia, dehydration and malnutrition.  CT chest showed increased left upper lobe mass, new left sided effusions, increased nodules, all worrisome for metastatic disease.  CT guided bx of lung mass via IR 1/27/22, negative for malignancy. Continued to deteriorate, transitioned to comfort care. Tx'd w/Vancomycin, Cefepime, flagyl, Zosyn, and  isavuconazonium. Expired on 2/9/2022
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Suicidal ideation
Clinical narrative: 2/1/2022 patient presented to ER for suicidal ideations. Tested positive for Covid-19.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, COVID-19, Leg amputation, Procedural haemorrhage, SARS-CoV-2 test positive
Clinical narrative: Patient presented with Wound Check to the hospital on 11/29/21 after a left below the knee amputation that she believes to be infected, as it is continuing to bleed. The patient explains that she is taking Doxycycline and Bactrim. She tested positive for COVID on 12/09.  Discharge plan was planed on 12/16. Pt remained very stable medically and asymptomatic for any covid related concern she wanted to finish her quarantine in the hospital and hence the discharge was  delayed and her stay for prolonged
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test abnormal, Dry mouth, Pollakiuria, Type 1 diabetes mellitus, Urine analysis
Clinical narrative: About a month after the second dose I started to have extreme dry mouth, frequent urination which last about a month. I lost about 20 lbs. in that month. I made a doctors appointment on 04/02/2021 and I had some bloodwork and urinalysis done. The next day I went to the emergency room. After about I week and a half I received my results and it showed I had type 1 diabetes. I have no family history of diabetes or autoimmune conditions.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: About a month after the second dose I started to have extreme dry mouth, frequent urination which last about a month. I lost about 20 lbs. in that month. I made a doctors appointment on 04/02/2021 and I had some bloodwork and urinalysis done. The next day I went to the emergency room. After about I week and a half I received my results and it showed I had type 1 diabetes. I have no family history of diabetes or autoimmune conditions.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash, Rash erythematous, Rash pruritic
Clinical narrative: Right after vaccine she thought she had 3 spider bites with 3 red dots, itchy on mid to R chest. Later developed vesicles. Rx antiviral for a week, ending today. Rash extended laterally and to upper R arm.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Injection site pain, Pain
Clinical narrative: Restriction of movement in left arm and severe pain in deltoid muscle beside bicep where the shot was administered.  When I move my arm in certain motions such as putting on a shirt/jacket, it feels like I am tearing/pulling the deltoid muscle. This only started filling the 2nd jab. Initially thought it was just sore from injection and would fade after a couple of days. It gradually got worse and still experiencing the pain nearly 6 months later. Now visiting a chiropractor who told me there are aware of about 15 other similar cases locally and the Covid shot seems to be the common denominator. I am only submitting this report now because I initially thought the pain was coincidental but it seems there may be a connection.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia
Clinical narrative: Patient admitted with Pneumonia of left lung due to infectious organism treated with to ceftriaxone and doxycycline for suspected pneumonia.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymph node pain, Lymphadenopathy, Mobility decreased, Ultrasound scan abnormal
Clinical narrative: I had bad chill without fever. For 48 hrs Swollen lymph node under my left arm side of a ping pong ball. It was extremely sore painful to touch and I couldn't move it. I went to the Dr a week after when it wasn't going away. They sent me to do an ultrasound.  Just confirm swollen lymph node. It can last six week and it was normal side affect. I went sent home afterward. Recommended to take Tylenol. It resolve on its own after 3 weeks.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Deafness, Ear discomfort, Loss of personal independence in daily activities
Clinical narrative: Ears are plugged and I cannot hear. This has lasted about two months. It went away for a day or two then came back.   My ability to perform normal functions is severely affected. My ears seemed to be stopped up.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Lymph node pain, Lymphadenopathy, Oedema peripheral, Peripheral swelling
Clinical narrative: Swelling of L arm, L axilla, L lateral breast. Development of L supraclavicular lymph node. Tenderness to palpation.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Pt had does Thursday morning, went to bed feeling fine with no complaints, found expired Friday am
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Acetabulum fracture, COVID-19, Hip fracture, Humerus fracture, SARS-CoV-2 test positive
Clinical narrative: Vaccinated patient tested positive with covid while admitted in inpatient facility
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: Vaccinated patient tested positive with covid while admitted in inpatient facility
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Caesarean section, Exposure during pregnancy
Clinical narrative: Patieint underwent a repeat low transverse cesarean section delivery without complication and was stable postoperatively on date. Hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Dizziness, Ear infection, Fall, Gait inability
Clinical narrative: 3 days after the vaccination, I was working and seated and suddenly I had a sensation of falling straight down. It continues at least 3/4 times a day and in April I had two days where I couldn't walk, I went to an urgent care on the last week of April bc I thought I had an ear infection. I had motion sickness from the dizziness I fell 05/01/2021 and my primary doctor referred to get an MRI of my brain and my abdomen because of how I fell and the bruising. I've been under the care of the Neurologist since June 2021 and started a RX Emgality and that is how they found out that I had migraines bc of the symptoms going right away after taking the medication. I see them regularly about the medication. The symptoms do come back every 23 days with the Emgality.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Magnetic resonance imaging head normal, Migraine, Motion sickness, Myoclonus
Clinical narrative: 3 days after the vaccination, I was working and seated and suddenly I had a sensation of falling straight down. It continues at least 3/4 times a day and in April I had two days where I couldn't walk, I went to an urgent care on the last week of April bc I thought I had an ear infection. I had motion sickness from the dizziness I fell 05/01/2021 and my primary doctor referred to get an MRI of my brain and my abdomen because of how I fell and the bruising. I've been under the care of the Neurologist since June 2021 and started a RX Emgality and that is how they found out that I had migraines bc of the symptoms going right away after taking the medication. I see them regularly about the medication. The symptoms do come back every 23 days with the Emgality.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Dizziness, Fatigue, Headache
Clinical narrative: I experienced dizziness, memory loss, headaches and fatigue.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Calculus urinary, Cystoscopy, Hydronephrosis, Ureteral stent insertion
Clinical narrative: Patient admitted for left ureteral stone and hydronephrosis. Cystoscopy with left ureteral stent placement. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood test, Cardiac stress test, Echocardiogram, Insomnia
Clinical narrative: EXTREME INSOMNIA, ANXIETY
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary normal, Aspergillus test negative, Back pain, Bacterial infection
Clinical narrative: Patient presented to ED after being seen at an urgent care on 11/26 with cough, congestion, and fevers that started on 11/13. He tested positive for COVID-19 and learned of his results the following day when he presented to the ED the following day on 11/27 for progressive symptoms. Additional symptoms included back pain and diarrhea. He received IV hydration. He had a virtual visit on 11/30, no reported hypoxia at that time, was febrile at 101, started on doxycycline 100 mg q.12 for 7 days. He presented the following day on 12/01 to ED, reporting feeling dehydrated and now with dysuria and worsening shortness of breath. Labs showed hyponatremia at 128, negative troponin, CTA negative for PE, prescribed Reglan. On 12/03 he had another virtual visit with his PCP, no reported hypoxia, worsening appetite, reporting very poor tolerance of oral doxycycline, doxycycline discontinued, started on Vantin. The patient presented to the ED with worsening back pain, cough, and diarrhea. Having worsening malaise, still febrile at home. Patient was admitted for COVID-19 infection/acute hypoxemic respiratory failure/CAP/immunosuppression. On 12/6 patient's oxygen requirements increased to 15L venti mask. Remdesivir was started. IV doxy was started in an effort to avoid GI distress. On 12/7 patient weaned to 6L but with worsening O2 sat was increased back to 15L. CXR ordered and noted to have worsening infiltrates. Respiratory cultures significant for gram negative rods, gram positive cocci and rods, all covered by the prescribed antibiotics. Patient found to be negative for C. pneumonia, C. Trichromatic, C psittaci, Strep pneumo, Aspergillus, and fungitell. Immunosuppressive medications held except for tacrolimus. Tacrolimus trough levels trended, and dose adjusted accordingly. Patient's oxygen requirements increased on 12/10 to non-rebreather mask, and high flow nasal cannula on 12/11. However on 12/12 patient was able to be downgraded to venti mask, and on 12/13 to 6L on NC. Antibiotics were stopped on 12/12 due to microbiology studies being negative. 12/13: Weaned to 6 L NC; Improving SOB. Pt/OT recommended post acute care. 12/14: Weaned to 5-4 L NC; improving SOB. O2 sat decreased to 86% with activity but recovered to 92% within 30 seconds. 12/16: Patient alert and fully oriented breathing room air. Reports that he feels much better, states that he would like to go home. He is eating well and denies CP abdominal pain. Some mild SOB when he is ambulating but is much improved from days prior. Patient was discharged to home on 12/17 in stable condition.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Chlamydia test negative, Cough, Decreased appetite
Clinical narrative: Patient presented to ED after being seen at an urgent care on 11/26 with cough, congestion, and fevers that started on 11/13. He tested positive for COVID-19 and learned of his results the following day when he presented to the ED the following day on 11/27 for progressive symptoms. Additional symptoms included back pain and diarrhea. He received IV hydration. He had a virtual visit on 11/30, no reported hypoxia at that time, was febrile at 101, started on doxycycline 100 mg q.12 for 7 days. He presented the following day on 12/01 to ED, reporting feeling dehydrated and now with dysuria and worsening shortness of breath. Labs showed hyponatremia at 128, negative troponin, CTA negative for PE, prescribed Reglan. On 12/03 he had another virtual visit with his PCP, no reported hypoxia, worsening appetite, reporting very poor tolerance of oral doxycycline, doxycycline discontinued, started on Vantin. The patient presented to the ED with worsening back pain, cough, and diarrhea. Having worsening malaise, still febrile at home. Patient was admitted for COVID-19 infection/acute hypoxemic respiratory failure/CAP/immunosuppression. On 12/6 patient's oxygen requirements increased to 15L venti mask. Remdesivir was started. IV doxy was started in an effort to avoid GI distress. On 12/7 patient weaned to 6L but with worsening O2 sat was increased back to 15L. CXR ordered and noted to have worsening infiltrates. Respiratory cultures significant for gram negative rods, gram positive cocci and rods, all covered by the prescribed antibiotics. Patient found to be negative for C. pneumonia, C. Trichromatic, C psittaci, Strep pneumo, Aspergillus, and fungitell. Immunosuppressive medications held except for tacrolimus. Tacrolimus trough levels trended, and dose adjusted accordingly. Patient's oxygen requirements increased on 12/10 to non-rebreather mask, and high flow nasal cannula on 12/11. However on 12/12 patient was able to be downgraded to venti mask, and on 12/13 to 6L on NC. Antibiotics were stopped on 12/12 due to microbiology studies being negative. 12/13: Weaned to 6 L NC; Improving SOB. Pt/OT recommended post acute care. 12/14: Weaned to 5-4 L NC; improving SOB. O2 sat decreased to 86% with activity but recovered to 92% within 30 seconds. 12/16: Patient alert and fully oriented breathing room air. Reports that he feels much better, states that he would like to go home. He is eating well and denies CP abdominal pain. Some mild SOB when he is ambulating but is much improved from days prior. Patient was discharged to home on 12/17 in stable condition.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Dehydration, Diarrhoea, Dyspnoea, Dysuria, Fungal test negative
Clinical narrative: Patient presented to ED after being seen at an urgent care on 11/26 with cough, congestion, and fevers that started on 11/13. He tested positive for COVID-19 and learned of his results the following day when he presented to the ED the following day on 11/27 for progressive symptoms. Additional symptoms included back pain and diarrhea. He received IV hydration. He had a virtual visit on 11/30, no reported hypoxia at that time, was febrile at 101, started on doxycycline 100 mg q.12 for 7 days. He presented the following day on 12/01 to ED, reporting feeling dehydrated and now with dysuria and worsening shortness of breath. Labs showed hyponatremia at 128, negative troponin, CTA negative for PE, prescribed Reglan. On 12/03 he had another virtual visit with his PCP, no reported hypoxia, worsening appetite, reporting very poor tolerance of oral doxycycline, doxycycline discontinued, started on Vantin. The patient presented to the ED with worsening back pain, cough, and diarrhea. Having worsening malaise, still febrile at home. Patient was admitted for COVID-19 infection/acute hypoxemic respiratory failure/CAP/immunosuppression. On 12/6 patient's oxygen requirements increased to 15L venti mask. Remdesivir was started. IV doxy was started in an effort to avoid GI distress. On 12/7 patient weaned to 6L but with worsening O2 sat was increased back to 15L. CXR ordered and noted to have worsening infiltrates. Respiratory cultures significant for gram negative rods, gram positive cocci and rods, all covered by the prescribed antibiotics. Patient found to be negative for C. pneumonia, C. Trichromatic, C psittaci, Strep pneumo, Aspergillus, and fungitell. Immunosuppressive medications held except for tacrolimus. Tacrolimus trough levels trended, and dose adjusted accordingly. Patient's oxygen requirements increased on 12/10 to non-rebreather mask, and high flow nasal cannula on 12/11. However on 12/12 patient was able to be downgraded to venti mask, and on 12/13 to 6L on NC. Antibiotics were stopped on 12/12 due to microbiology studies being negative. 12/13: Weaned to 6 L NC; Improving SOB. Pt/OT recommended post acute care. 12/14: Weaned to 5-4 L NC; improving SOB. O2 sat decreased to 86% with activity but recovered to 92% within 30 seconds. 12/16: Patient alert and fully oriented breathing room air. Reports that he feels much better, states that he would like to go home. He is eating well and denies CP abdominal pain. Some mild SOB when he is ambulating but is much improved from days prior. Patient was discharged to home on 12/17 in stable condition.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Gram stain positive, Hyponatraemia, Immunosuppression, Laboratory test abnormal, Lung infiltration
Clinical narrative: Patient presented to ED after being seen at an urgent care on 11/26 with cough, congestion, and fevers that started on 11/13. He tested positive for COVID-19 and learned of his results the following day when he presented to the ED the following day on 11/27 for progressive symptoms. Additional symptoms included back pain and diarrhea. He received IV hydration. He had a virtual visit on 11/30, no reported hypoxia at that time, was febrile at 101, started on doxycycline 100 mg q.12 for 7 days. He presented the following day on 12/01 to ED, reporting feeling dehydrated and now with dysuria and worsening shortness of breath. Labs showed hyponatremia at 128, negative troponin, CTA negative for PE, prescribed Reglan. On 12/03 he had another virtual visit with his PCP, no reported hypoxia, worsening appetite, reporting very poor tolerance of oral doxycycline, doxycycline discontinued, started on Vantin. The patient presented to the ED with worsening back pain, cough, and diarrhea. Having worsening malaise, still febrile at home. Patient was admitted for COVID-19 infection/acute hypoxemic respiratory failure/CAP/immunosuppression. On 12/6 patient's oxygen requirements increased to 15L venti mask. Remdesivir was started. IV doxy was started in an effort to avoid GI distress. On 12/7 patient weaned to 6L but with worsening O2 sat was increased back to 15L. CXR ordered and noted to have worsening infiltrates. Respiratory cultures significant for gram negative rods, gram positive cocci and rods, all covered by the prescribed antibiotics. Patient found to be negative for C. pneumonia, C. Trichromatic, C psittaci, Strep pneumo, Aspergillus, and fungitell. Immunosuppressive medications held except for tacrolimus. Tacrolimus trough levels trended, and dose adjusted accordingly. Patient's oxygen requirements increased on 12/10 to non-rebreather mask, and high flow nasal cannula on 12/11. However on 12/12 patient was able to be downgraded to venti mask, and on 12/13 to 6L on NC. Antibiotics were stopped on 12/12 due to microbiology studies being negative. 12/13: Weaned to 6 L NC; Improving SOB. Pt/OT recommended post acute care. 12/14: Weaned to 5-4 L NC; improving SOB. O2 sat decreased to 86% with activity but recovered to 92% within 30 seconds. 12/16: Patient alert and fully oriented breathing room air. Reports that he feels much better, states that he would like to go home. He is eating well and denies CP abdominal pain. Some mild SOB when he is ambulating but is much improved from days prior. Patient was discharged to home on 12/17 in stable condition.